PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Precipio, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Precipio, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.
  • Debt Due Cover Ratio: Debt due within a year is covered 22.8 times by its yearly operating cash. Higher than 90% of Healthcare companies in United States.

Where $100 of sales goes

$105Operating costs$0.3Interest$1.5Net loss

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

-3.6×

Over the last 3 years operating cash was negative while the company kept spending on investment (capex).

Higher than 57% of Healthcare companies in United States.

Cash Locked Ratio

$7

For every $100 of sales, $7 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $4 from others' credit three years earlier.

Less money tied up than 84% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

3/3 · 3/3

Sales and profit both grew in each of the last 3 years.

Steadier than 96% of Healthcare companies in United States.

Growth Efficiency Ratio

$81

Sales grew 156% in 3 years; of every extra $100 of sales, $81 became extra profit.

Higher than 78% of Healthcare companies in United States.

Asset Productivity Ratio

+156% / -1%

In 3 years sales changed by +156% while total assets changed by -1%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

22.8×

Debt due within a year is covered 22.8 times by its yearly operating cash.

Higher than 90% of Healthcare companies in United States.

Cash Cushion Ratio

−3%

Debt, after subtracting cash, equals 3% of its market value (net debt).

Lower than 72% of Healthcare companies in United States.

Tangible Assets Ratio

49%

Of every $100 the company owns, $49 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 82% of Healthcare companies in United States.

Tangible Net Worth Ratio

25%

Of every $100 of net worth, $25 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

Less tangible than 63% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+56%

Share count rose 56% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 59% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Precipio, Inc. made a loss over the last year. Precipio, Inc. owes $0.31 for every $1 it owns. Precipio, Inc. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Precipio, Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

2.43

The share price is 2.43 times Precipio, Inc.'s book value per share, lower than 52% of Healthcare companies in United States.

Market cap

$36 M

The total market value of all of Precipio, Inc.'s shares at today's price (share price × number of shares), smaller than 78% of Healthcare companies in United States. PosiCap size class: Micro Cap.

Net worth (book value)

$15 M

What Precipio, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$8.24

Net worth divided by the number of shares. The share price of $20.01 is 2.4 times this, which is the P/B above.

Return on equity (ROE)

-9.0%

Precipio, Inc. lost 9.0% of its shareholders' money over the last year, higher than 72% of Healthcare companies in United States.

Owes vs Owns

0.31×

Precipio, Inc. owes $0.31 for every $1 it owns (low), lower than 59% of Healthcare companies in United States.

Dividend yield

None

Precipio, Inc. does not currently pay a dividend.

Revenue growth

+30%

Revenue rose 30% in the year to Dec 2025, and grew 37% a year on average over 3 years.

Profit growth

Loss

Precipio, Inc. made a loss in each of the last two years.

Profit margin

-1.5%

Precipio, Inc. lost $2 for every $100 of revenue.

Interest cover

Not covered

Precipio, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net debt

Precipio, Inc. had $1 M more debt than cash (net debt) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Precipio, Inc.: $36 M ÷ $15 M (30 Jun 2026) = 2.4.

What is Precipio, Inc.'s return on equity?

Precipio, Inc. lost 9.0% of its shareholders' money over the last year, higher than 72% of Healthcare companies in United States.

How much does Precipio, Inc. owe compared with what it owns?

Precipio, Inc. owes $0.31 for every $1 it owns (low), lower than 59% of Healthcare companies in United States.

Does Precipio, Inc. pay a dividend?

No. Precipio, Inc. does not currently pay a dividend.

Is Precipio, Inc.'s revenue growing?

Revenue rose 30% in the year to Dec 2025, and grew 37% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.